Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA polymerase II-associated protein 1 (RPAP1) is a large, evolutionarily conserved protein identified as a component that physically associates with the RNA polymerase II (RNAPII) complex in human cells[3][4]. It does not possess a clearly defined catalytic activity or domain but may play a role in recruiting or stabilizing RNAPII at chromatin, thereby impacting transcriptional regulation. RPAP1 shares homology with essential proteins in yeast required for cell viability and gene expression, suggesting a conserved but possibly non-catalytic role in transcriptional processes. RPAP1 may also belong to the Armadillo (ARM) repeat protein superfamily, although definitive structural motifs were not confirmed. Its precise functional contributions, particularly in human cells, remain under investigation[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA polymerase II-associated protein 1 (RPAP1).